Biotech · Private company · Towson, MD, US
Cometa Therapeutics Inc
Track this companyFree. Adds Cometa Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1bFiscal year 2026 · $845.4KNIH RePORTER 4R42DK141304-02 · fetched Nov 12, 2026
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1bFiscal year 2025 · $299.6KNIH RePORTER 1R42DK141304-01A1 · fetched Nov 12, 2026